Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Teliso-V
Teliso-V
AbbVie Gets Phase II NSCLC Win for ADC, Looks to Accelerated Approval
BioSpace
Fri, 12/1/23 - 11:23 am
AbbVie
Teliso-V
antibody-drug conjugate
non-small cell lung cancer
AbbVie cues up filing for c-Met ADC in lung cancer
Pharmaphorum
Wed, 11/29/23 - 12:00 pm
AbbVie
Teliso-V
clinical trials
lung cancer
FDA grants breakthrough designation to AbbVie’s Teliso-V for NSCLC treatment
Pharmaceutical Business Review
Wed, 01/5/22 - 10:33 am
FDA
AbbVie
Teliso-V
telisotuzumab vedotin
non-small cell lung cancer